Literature DB >> 9464731

Does delivery improve maternal condition in the respiratory-compromised gravida?

M W Tomlinson1, T J Caruthers, J E Whitty, B Gonik.   

Abstract

OBJECTIVE: To describe the effect of delivery on respiratory status and outcome in the respiratory-compromised pregnant woman.
METHODS: During 1990-1994, 10 patients requiring intubation for respiratory compromise who delivered during ventilatory support were identified by International Classification of Diseases, Ninth Revision codes. Charts were reviewed retrospectively for cardiorespiratory variables and outcome.
RESULTS: Pneumonia led to intubation in all but one case. The onset of labor was spontaneous in eight. Three were delivered by cesarean. Mechanical ventilation was used for a median (range) of 7 (2-22) days in surviving patients. Fraction of inspired oxygen requirements decreased an average of 28% by 24 hours after delivery. Positive end-expiratory pressure requirements remained unaltered. Surviving patients remained intubated for a median (range) of 2.6 (1-19) days postpartum. Three women died, all after vaginal delivery (days 4-14).
CONCLUSION: Delivery of respiratory-compromised gravidas resulted in a 28% reduction in fraction of inspired oxygen requirement within 24 hours after delivery. Although most patients were then able to be maintained below critical fraction of inspired oxygen requirement levels (under 0.6), dramatic improvement in overall respiratory function was not observed uniformly. Given the limited benefit of delivery on maternal oxygenation, along with the inherent risks of labor induction in this critically ill population, caution should be exercised in initiating the induction process electively.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9464731     DOI: 10.1016/s0029-7844(97)00585-1

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  19 in total

1.  Normal delivery induced stress alters glutathione peroxidase and TNF-α in elderly primigravidas mononuclear cells.

Authors:  Nasreen Noor; Najmul Islam; Shagufta Moin; Abbas Ali Mahdi; Sapna Jaiswal; Farzana Bano
Journal:  Indian J Clin Biochem       Date:  2008-10-01

Review 2.  Maternal critical care: part I.

Authors:  Anita Banerjee; Steve Cantellow
Journal:  BJA Educ       Date:  2021-02-05

3.  Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study.

Authors: 
Journal:  BMJ       Date:  2010-03-18

4.  Pregnancy complicated by influenza A ARDS requiring consecutive VV-ECMO treatment with successful vaginal delivery.

Authors:  Peter Radsel; Vojka Gorjup; Anja Jazbec; Rihard Knafelj; Miha Lucovnik; Gorazd Kavsek; Lilijana Kornhauser Cerar; Marko Noc
Journal:  J Artif Organs       Date:  2018-05-17       Impact factor: 1.731

5.  Clinical profile & outcome of H1N1 infected pregnant women in a tertiary care teaching hospital of northern India.

Authors:  Seema Singhal; Nivedita Sarda; Renu Arora; Nikky Punia; Anil Jain
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375

Review 6.  Acute respiratory failure in pregnancy.

Authors:  Stephen E Lapinsky
Journal:  Obstet Med       Date:  2015-06-10

7.  Maternal and fetal recovery after severe respiratory failure due to influenza: a case report.

Authors:  Kristine Madsen; Ditte Gry Strange; Morten Hedegaard; Elisabeth R Mathiesen; Peter Damm
Journal:  BMC Res Notes       Date:  2013-02-15

8.  Pregnancy complicated by Ludwig's angina requiring delivery.

Authors:  Kathleen Moorhead; Maryam Guiahi
Journal:  Infect Dis Obstet Gynecol       Date:  2010-06-10

Review 9.  [Severe forms of influenza A (H1N1) 2009 in pregnant women: experience of the University Hospital of Fez, Morocco and literature review].

Authors:  Mohamed Adnane Berdai; Smael Labib; Mustapha Harandou
Journal:  Pan Afr Med J       Date:  2012-02-29

Review 10.  Fetal outcome in the critically ill pregnant woman.

Authors:  Kazuyoshi Aoyama; P Gareth Seaward; Stephen E Lapinsky
Journal:  Crit Care       Date:  2014-05-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.